A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention in Children and Adolescents = 6 to <18 years of age

Objective

Clinical Trial Details >>

Principal Investigator(s)
Connie Taylor, MD

Clinical Trial Categories

  • Pediatrics
Sponsor(s)
Pfizer
Contact
Avera Research Institute at 605-504-3154
or ARI@Avera.org

Location

  • Avera Medical Group Pediatric Specialists — Plaza 1
    1417 S Cliff Ave
    Plaza 1, Suites 010 & 101A
    Sioux Falls, SD 57105
    Main: 605-322-3666
    Alternate: 888-315-3666
    Fax: 605-322-3665
  • Avera Research Institute — Sioux Falls
    6001 S Sharon Ave
    Sioux Falls, SD 57108
    Main: 605-504-3154